Conversion of the neurotoxic precursor 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine into its pyridinium metabolite by human platelet monoamine oxidase type B-Reference-Cited by-同舟云学术

Conversion of the neurotoxic precursor 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine into its pyridinium metabolite by human platelet monoamine oxidase type B

Published:1985-06 Issue:3 Volume:57 Page:257-262
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Da Prada M.,Cesura A.M.,Kettler R.,Zürcher G.,Haefely W.E.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference22 articles.

1. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;Burns,1983

2. Potent and long-lasting potentiation of two 5-hydroxytryptophan-induced effects in mice by three selective 5-HT uptake inhibitors;Buus-Lassen;Europ. J. Pharmacol.,1978

3. Aetiology of Parkinson's disease;Calne;Lancet,1983

4. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP);Castagnoli;Life Sci.,1985

5. Effect of monoamine liberators on the metabolism of 5-hydroxytryptamine in blood platelets;Da Prada;Biochem. Pharmacol.,1965

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinal Degeneration Following Chronic Administration of the Parkinsonism-Inducing Neurotoxin MPTP;Archives Italiennes de Biologie;2021

2. Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression;Acta Psychiatrica Scandinavica;1997-08

3. Double-Blind Randomized Controlled Pilot Study of the Efficacy and Tolerability of Pirlindole, a Reversible Inhibitor of Monoamine Oxidase A, and Mianserin, in the Treatment of Depression;Human Psychopharmacology: Clinical and Experimental;1997-01

4. A double-blind randomized placebo-controlled study of the efficacy and safety of pirlindole, a reversible monoamine oxidase A inhibitor, in the treatment of depression;Acta Psychiatrica Scandinavica;1996-12

5. Clinical overview on moclobemide;Progress in Neuro-Psychopharmacology and Biological Psychiatry;1993-09